Telehealth is booming during the COVID-19 pandemic. Not only are people paying close attention to their health because of the disease, stay-at-home orders mean that people are shifting aspects of their lives online. These two factors are a boon for telehealth providers, and healthtech startup Medici has experienced this firsthand.
On Monday, Medici announced the closing of its $24 million Series B funding round. This new funding will help the company expand its impact as it experiences rapid growth.
Medici has designed a HIPAA-compliant healthcare platform that allows patients to text, call or video chat with their doctors. And unlike other telehealth companies, Medici says that patients can keep their doctors instead of being paired with new ones. Over 25,000 healthcare providers use Medici, including specialists ranging from dentists to pediatricians, to surgeons and veterinarians.
Medici says it has seen rapid adoption lately, with a 1,409 percent increase in patient registrations from February to April. The amount of patient consultations has gone up dramatically too. The company hopes to continue this momentum and become a household name.
“We are thrilled to have remarkable investors who really want to see lives and healthcare transformed,” Medici CEO Clint Phillips said in a statement. “Unlike Zoom or FaceTime, Medici allows you to text, ePrescribe, Refer, group chat, bill, translate, triage, keep your number private, your consults organized, and gives $1m liability insurance to physicians. This investment will allow us to invest further into our team and technology to truly impact global healthcare.”
